Compile Data Set for Download or QSAR
Report error Found 24 Enz. Inhib. hit(s) with all data for entry = 12182
TargetPoly [ADP-ribose] polymerase 2(Human)
Enliven

US Patent
LigandPNGBDBM684688(US20240228486, Compound 2.8)
Affinity DataIC50: 0.515nMAssay Description:Compounds were dissolved and 4-fold serially diluted in DMSO. Compounds were transferred by an Echo to the assay plate to reach final concentrations ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/22/2024
Entry Details
US Patent

TargetPoly [ADP-ribose] polymerase 2(Human)
Enliven

US Patent
LigandPNGBDBM684688(US20240228486, Compound 2.8)
Affinity DataIC50: 0.515nMAssay Description:Compounds were dissolved and 4-fold serially diluted in DMSO. Compounds were transferred by an Echo to the assay plate to reach final concentrations ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/22/2024
Entry Details
US Patent

TargetPoly [ADP-ribose] polymerase 2(Human)
Enliven

US Patent
LigandPNGBDBM684685(US20240228486, Compound 2.5 | 7-((1-(2,4-difluorop...)
Affinity DataIC50: 3.65nMAssay Description:Compounds were dissolved and 4-fold serially diluted in DMSO. Compounds were transferred by an Echo to the assay plate to reach final concentrations ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/22/2024
Entry Details
US Patent

TargetPoly [ADP-ribose] polymerase 2(Human)
Enliven

US Patent
LigandPNGBDBM684683(US20240228486, Compound 2.3)
Affinity DataIC50: 3.66nMAssay Description:Compounds were dissolved and 4-fold serially diluted in DMSO. Compounds were transferred by an Echo to the assay plate to reach final concentrations ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/22/2024
Entry Details
US Patent

TargetPoly [ADP-ribose] polymerase 2(Human)
Enliven

US Patent
LigandPNGBDBM684681(US20240228486, Compound 2.1)
Affinity DataIC50: 4.97nMAssay Description:Compounds were dissolved and 4-fold serially diluted in DMSO. Compounds were transferred by an Echo to the assay plate to reach final concentrations ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/22/2024
Entry Details
US Patent

TargetPoly [ADP-ribose] polymerase 2(Human)
Enliven

US Patent
LigandPNGBDBM684681(US20240228486, Compound 2.1)
Affinity DataIC50: 4.97nMAssay Description:Compounds were dissolved and 4-fold serially diluted in DMSO. Compounds were transferred by an Echo to the assay plate to reach final concentrations ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/22/2024
Entry Details
US Patent

TargetPoly [ADP-ribose] polymerase 2(Human)
Enliven

US Patent
LigandPNGBDBM684681(US20240228486, Compound 2.1)
Affinity DataIC50: 6.18nMAssay Description:Compounds were dissolved and 4-fold serially diluted in DMSO. Compounds were transferred by an Echo to the assay plate to reach final concentrations ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/22/2024
Entry Details
US Patent

TargetPoly [ADP-ribose] polymerase 2(Human)
Enliven

US Patent
LigandPNGBDBM684687(US20240228486, Compound 2.7)
Affinity DataIC50: 6.89nMAssay Description:Compounds were dissolved and 4-fold serially diluted in DMSO. Compounds were transferred by an Echo to the assay plate to reach final concentrations ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/22/2024
Entry Details
US Patent

TargetPoly [ADP-ribose] polymerase 2(Human)
Enliven

US Patent
LigandPNGBDBM684688(US20240228486, Compound 2.8)
Affinity DataIC50: 8.66nMAssay Description:Compounds were dissolved and 4-fold serially diluted in DMSO. Compounds were transferred by an Echo to the assay plate to reach final concentrations ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/22/2024
Entry Details
US Patent

TargetPoly [ADP-ribose] polymerase 2(Human)
Enliven

US Patent
LigandPNGBDBM684683(US20240228486, Compound 2.3)
Affinity DataIC50: 9.11nMAssay Description:Compounds were dissolved and 4-fold serially diluted in DMSO. Compounds were transferred by an Echo to the assay plate to reach final concentrations ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/22/2024
Entry Details
US Patent

TargetPoly [ADP-ribose] polymerase 2(Human)
Enliven

US Patent
LigandPNGBDBM684683(US20240228486, Compound 2.3)
Affinity DataIC50: 9.11nMAssay Description:Compounds were dissolved and 4-fold serially diluted in DMSO. Compounds were transferred by an Echo to the assay plate to reach final concentrations ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/22/2024
Entry Details
US Patent

TargetPoly [ADP-ribose] polymerase 2(Human)
Enliven

US Patent
LigandPNGBDBM684687(US20240228486, Compound 2.7)
Affinity DataIC50: 10.8nMAssay Description:Compounds were dissolved and 4-fold serially diluted in DMSO. Compounds were transferred by an Echo to the assay plate to reach final concentrations ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/22/2024
Entry Details
US Patent

TargetPoly [ADP-ribose] polymerase 2(Human)
Enliven

US Patent
LigandPNGBDBM684687(US20240228486, Compound 2.7)
Affinity DataIC50: 10.8nMAssay Description:Compounds were dissolved and 4-fold serially diluted in DMSO. Compounds were transferred by an Echo to the assay plate to reach final concentrations ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/22/2024
Entry Details
US Patent

TargetPoly [ADP-ribose] polymerase 2(Human)
Enliven

US Patent
LigandPNGBDBM684684(US20240228486, Compound 2.4)
Affinity DataIC50: 23.9nMAssay Description:Compounds were dissolved and 4-fold serially diluted in DMSO. Compounds were transferred by an Echo to the assay plate to reach final concentrations ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/22/2024
Entry Details
US Patent

TargetPoly [ADP-ribose] polymerase 2(Human)
Enliven

US Patent
LigandPNGBDBM684682(US20240228486, Compound 2.2)
Affinity DataIC50: 27.1nMAssay Description:Compounds were dissolved and 4-fold serially diluted in DMSO. Compounds were transferred by an Echo to the assay plate to reach final concentrations ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/22/2024
Entry Details
US Patent

TargetPoly [ADP-ribose] polymerase 2(Human)
Enliven

US Patent
LigandPNGBDBM684685(US20240228486, Compound 2.5 | 7-((1-(2,4-difluorop...)
Affinity DataIC50: 151nMAssay Description:Compounds were dissolved and 4-fold serially diluted in DMSO. Compounds were transferred by an Echo to the assay plate to reach final concentrations ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/22/2024
Entry Details
US Patent

TargetPoly [ADP-ribose] polymerase 2(Human)
Enliven

US Patent
LigandPNGBDBM684685(US20240228486, Compound 2.5 | 7-((1-(2,4-difluorop...)
Affinity DataIC50: 151nMAssay Description:Compounds were dissolved and 4-fold serially diluted in DMSO. Compounds were transferred by an Echo to the assay plate to reach final concentrations ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/22/2024
Entry Details
US Patent

TargetPoly [ADP-ribose] polymerase 2(Human)
Enliven

US Patent
LigandPNGBDBM684682(US20240228486, Compound 2.2)
Affinity DataIC50: 180nMAssay Description:Compounds were dissolved and 4-fold serially diluted in DMSO. Compounds were transferred by an Echo to the assay plate to reach final concentrations ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/22/2024
Entry Details
US Patent

TargetPoly [ADP-ribose] polymerase 2(Human)
Enliven

US Patent
LigandPNGBDBM684682(US20240228486, Compound 2.2)
Affinity DataIC50: 180nMAssay Description:Compounds were dissolved and 4-fold serially diluted in DMSO. Compounds were transferred by an Echo to the assay plate to reach final concentrations ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/22/2024
Entry Details
US Patent

TargetPoly [ADP-ribose] polymerase 2(Human)
Enliven

US Patent
LigandPNGBDBM684684(US20240228486, Compound 2.4)
Affinity DataIC50: 890nMAssay Description:Compounds were dissolved and 4-fold serially diluted in DMSO. Compounds were transferred by an Echo to the assay plate to reach final concentrations ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/22/2024
Entry Details
US Patent

TargetPoly [ADP-ribose] polymerase 2(Human)
Enliven

US Patent
LigandPNGBDBM684684(US20240228486, Compound 2.4)
Affinity DataIC50: 890nMAssay Description:Compounds were dissolved and 4-fold serially diluted in DMSO. Compounds were transferred by an Echo to the assay plate to reach final concentrations ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/22/2024
Entry Details
US Patent

TargetPoly [ADP-ribose] polymerase 2(Human)
Enliven

US Patent
LigandPNGBDBM684686(US20240228486, Compound 2.6)
Affinity DataIC50: 1.00E+3nMAssay Description:Compounds were dissolved and 4-fold serially diluted in DMSO. Compounds were transferred by an Echo to the assay plate to reach final concentrations ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/22/2024
Entry Details
US Patent

TargetPoly [ADP-ribose] polymerase 2(Human)
Enliven

US Patent
LigandPNGBDBM684686(US20240228486, Compound 2.6)
Affinity DataIC50: 1.00E+3nMAssay Description:Compounds were dissolved and 4-fold serially diluted in DMSO. Compounds were transferred by an Echo to the assay plate to reach final concentrations ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/22/2024
Entry Details
US Patent

TargetPoly [ADP-ribose] polymerase 2(Human)
Enliven

US Patent
LigandPNGBDBM684686(US20240228486, Compound 2.6)
Affinity DataIC50: 1.00E+4nMAssay Description:Compounds were dissolved and 4-fold serially diluted in DMSO. Compounds were transferred by an Echo to the assay plate to reach final concentrations ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/22/2024
Entry Details
US Patent